Hereditary angioedema (HAE) is clinically characterized by recurrent and self-limiting skin, intestinal, and life-threatening laryngeal edema. This study describes the age at which laryngeal edema first occurred, the time between onset and full development, and the effectiveness of therapy and prophylaxis in 123 HAE patients. 61 (49.7%) patients experienced a total of 596 laryngeal edema episodes. The ratio of laryngeal edema episodes to skin swellings and abdominal pain attacks was approximately 1:70:54 in patients who had laryngeal edema. The mean (SD) age at the first laryngeal edema was 26.2 (15.3) years. Nearly 80% of the laryngeal edemas occurred between age 11 and 45. The mean interval between onset and maximum development of laryngeal edema was 8.3 hours. A total of 354 laryngeal edemas cleared spontaneously without treatment and 208 laryngeal edemas were successfully treated with C1 inhibitor concentrate. Despite long-term prophylactic treatment with danazol, 6 patients developed subsequent laryngeal edemas. Laryngeal edema may occur at any age, although young adults are at greatest risk. In adults, the interval between onset of symptoms and acute risk of asphyxiation is usually long enough to allow for use of appropriate emergency procedures. It is essential to instruct patients and their relatives about the first signs of laryngeal edemas and the necessary procedures to follow.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Transfusion and Apheresis Science
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Hereditary angioneurotic edema.J. Allergy Clin. Immunol. 1962; 33: 316-329
- Hereditary angioedema: an appraisal of 104 cases.Am. J. Med. Sci. 1982; 284: 2-9
- Asphyxiation by laryngeal edema in patients with hereditary angioedema.Mayo. Clin. Proc. 2000; 75: 349-354
- Über akutes umschriebenes Hautödem.Monatsh Prakt Dermatol. 1882; 1: 129-131
- Hereditary angioneurotic edema.Am. J. Med. Sci. 1888; 95: 362-367
- Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor.N. Engl. J. Med. 1980; 302: 542-546
- Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate.N. Engl. J. Med. 1996; 334: 1630-1634
- A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema.Transfusion. 1998; 38: 540-549
- C1-esterase inhibitor transfusions in patients with hereditary angioedema.Ann. Allergy Asthma Immunol. 1998; 80: 457-461
- Treatment of hereditary angioedema.Klin. Wochenschr. 1978; 56: 819-823
- Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate.Ann. Allergy. 1980; 44: 299-301
- C1 INH concentrate in the therapy of hereditary angioedema.Allergy. 1983; 38: 81-84
- Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema.Arch. Int. Med. 2001; 161: 714-718
- Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 inhibitor deficiency.Arch. Int. Med. 2003; 163: 1229-1235
- Management of the airway in patients with angioedema.Laryngoscope. 1983; 93: 749-754
- C1 esterase inhibitor deficiency, airway compromise, and anesthesia.Anesth. Analg. 1998; 87: 480-488
© 2003 Published by Elsevier Inc.